2024 arşivleri - GEN

GEN Won the Bronze Award from the 2024 Brandon Hall Group HCM Excellence Awards®!

GEN Won the Bronze Award from the 2024 Brandon Hall Group HCM…

userSeptember 17, 2024

GEN Once Again on the Fortune 500 Türkiye List!

GEN Once Again on the Fortune 500 Türkiye List! We are ranked…

<img alt='user' data-src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='user' src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

userJuly 19, 2024

GEN has signed an important partnership and collaboration agreement with Jaguar Health Inc.

GEN has signed an important partnership and collaboration agreement with Jaguar Health.…

<img alt='user' data-src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='user' src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

userMarch 20, 2024

2024 2024 2024 2024

GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238

GEN initiates Phase 1 study of the first-in-class investigational drug SUL-238 Ankara,…

<img alt='user' data-src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='user' src='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/b58996c504c5638798eb6b511e6f49af?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

userFebruary 22, 2024

Corporate

Products – Türkiye

Products – International

About Us

Support

Information Society Services

Information Security Policy

GEN Energy Policy

All rights reserved © 2024 Gen İlaç ve Sağlık Ürünleri A.Ş. The information on our site cannot replace a healthcare professional consultancy. Products page is for healthcare professionals only.